Chordia Therapeutics (TSE:190A) Other Stockholders Equity: 円9.66 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:190A Chordia Therapeutics Inc TSE:190A
12 GF Score
Price 円78.00
! 2 Warning Signs
View Full Analysis

What is Chordia Therapeutics Other Stockholders Equity?

Chordia Therapeutics TSE:190A 12 Other Stockholders Equity is 円9.66 Mil as of Feb. 2026. GuruFocus rates TSE:190A with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Chordia Therapeutics's Other Stockholders Equity for the quarter that ended in Feb. 2026 was 円9.66 Mil.

Chordia Therapeutics's quarterly Other Stockholders Equity stayed the same from Feb. 2025 (円2.52 Mil) to Aug. 2025 (円2.52 Mil) but then increased from Aug. 2025 (円2.52 Mil) to Feb. 2026 (円9.66 Mil).

Chordia Therapeutics's annual Other Stockholders Equity declined from Aug. 2023 (円25.93 Mil) to Aug. 2024 (円2.94 Mil) and declined from Aug. 2024 (円2.94 Mil) to Aug. 2025 (円2.52 Mil).

Chordia Therapeutics Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Chordia Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chordia Therapeutics Other Stockholders Equity Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24 Aug25
Other Stockholders Equity
3,432.79 5,432.87 25.93 2.94 2.52

Chordia Therapeutics Semi-Annual Data
Aug21 Aug22 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Other Stockholders Equity Get a 7-Day Free Trial 0.00 2.94 2.52 2.52 9.66
TSE:190A
12GF Score
Chordia Therapeutics Inc TSE:190A
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chordia Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of 円9.66 Mil mean?
Chordia Therapeutics (TSE:190A) has a Other Stockholders Equity of 円9.66 Mil as of Feb. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Chordia Therapeutics and its competitors.
Is Chordia Therapeutics' Other Stockholders Equity too high?
Chordia Therapeutics' current Other Stockholders Equity is 円9.66 Mil. Overall, Chordia Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Chordia Therapeutics' Other Stockholders Equity compare to VRTX and REGN?
Chordia Therapeutics' Other Stockholders Equity of 円9.66 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Chordia Therapeutics and its competitors. Chordia Therapeutics's current Other Stockholders Equity is 円9.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chordia Therapeutics stock overvalued right now?
Chordia Therapeutics (TSE:190A) has a current Other Stockholders Equity of 円9.66 Mil. The current Other Stockholders Equity is 円9.66 Mil. Chordia Therapeutics' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Chordia Therapeutics (TSE:190A), the current Other Stockholders Equity is 円9.66 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chordia Therapeutics Business Description

Address 2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.
12GF Score

Get the complete analysis for TSE:190A

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円78.00
Price